Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

  • Bacterial sialometabolic activity impacts periodontal immunity and microbiota. Yijun Sun (Co-Investigator). NIH. $1,930,340. 9/1/2020-8/1/2025.
  • Advanced computational approaches to delineating dynamic cancer progression processes by using massive static sample data. Yijun Sun (Principal Investigator). NIH. $1,964,300. 4/1/2020-3/1/2025.
  • The Organization and Function of the Toxoplasma Daughter Cell Scaffold. Ira Blader (Co-Principal Investigator). NIH. 1/1/2020-12/1/2024.
  • Conserved Proteus mirabilis genetic requirements for colonization of the catheterized urinary tract. Chelsie Armbruster (Principal Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. 9/1/2019-5/1/2024.
  • Function and regulation of the essential RNA binding protein, DRBD18. Laurie Read (Principal Investigator). NIH. $2,121,078. 6/1/2019-5/1/2024.
  • The role of the extracellular adenosine pathway and neutrophils during infective endocarditis induced by S. pneumoniae. Elsa Bou Ghanem (Contributor). American Heart Association-Postdoctoral Fellowship to Manmeet Bhalla. $136,750. 4/1/2021-3/1/2023.
  • Features of PMN senescence that lead to susceptibility to pneumococcal infection. Elsa Bou Ghanem (Co-Investigator). NIA-R21. $469,115. 3/1/2021-2/1/2023.
  • Electrical Stimulation for Infection Control of the Skin-Implant Interface of Osseointegrated Prostheses. Anthony Campagnari (Co-Investigator). Peer Reviewed Orthopedic Research Program of the Congressionally Directed Medical Research Program. $7,490,000. 9/1/2020-8/1/2022.
  • Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae. Yijun Sun (Co-Investigator). NIH. $431,682. 8/1/2020-7/1/2022.
  • The microbiome in the etiology and prevention of breast cancer. Yijun Sun (Co-Investigator). NYS Department of Health. $359,000. 1/1/2019-7/1/2022.
  • Kinetoplastid RNA editing. Laurie Read (Principal Investigator). NIH. $1,232,000. 7/1/2018-6/1/2022.
  • Genetic susceptibility to mucosal infections with aging. Chelsie Armbruster (Co-Principal Investigator). National Institute of Allergy and Infectious Diseases. 6/1/2020-5/1/2022.
  • Genetic susceptibility to mucosal infections with aging. Elsa Bou Ghanem (Co-Principal Investigator). NIAID-R21. $438,625. 6/1/2020-5/1/2022.
  • The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responses. Elsa Bou Ghanem (Principal Investigator). NIA-R56. $322,105. 6/1/2021-5/1/2022.
  • Stress Responsive Reprogramming of Translating mRNA Pools in C. neoformans. John Panepinto (Principal Investigator). NIAID. $1,932,170. 5/1/2017-4/1/2022.
  • Stress responsive reprogramming of translating mRNA pools in C. neoformans. Yijun Sun (Co-Investigator). NIH. $2,000,000. 5/1/2017-4/1/2022.
  • Antibody Fragments as Biochemical Tools to Interrogate CD9 Function in Inflammatory Diseases. Elizabeth Wohlfert (Co-Principal Investigator). NIH/NIGMS. 5/1/2020-4/1/2022.
  • Identification of F-Box Proteins in Toxoplasma. Ira Blader (Co-Principal Investigator). NIH. 4/1/2020-3/1/2022.
  • Identification of new ribosylation-dependent immunoregulatory factors. Terry Connell (Principal Investigator). The National Institute of Allergy and Infectious Disease, NIH. 4/1/2020-3/1/2022.
  • Control of Toxoplasma gondii Growth by the Host Cell Transcription Factor HIF1. Ira Blader (Co-Investigator). NIH/NIAID. 4/1/2006-1/1/2022.